Mark J. Smyth

Mark J. Smyth

300 Herston Road
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 283 publications

Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Journal: Nature immunology

Published: June 29, 2026

Correction: Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy.

Correction: Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy.

Journal: The Journal of experimental medicine

Published: February 12, 2026

Author Correction: CD8+ T cells induce cachexia during chronic viral infection.

Author Correction: CD8+ T cells induce cachexia during chronic viral infection.

Journal: Nature immunology

Published: November 20, 2025

Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.

Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.

Journal: Nature communications

Published: December 05, 2024

TIGIT predominantly regulates the immune response via regulatory T cells.

TIGIT predominantly regulates the immune response via regulatory T cells.

Journal: The Journal of clinical investigation

Published: July 01, 2024

NK cell heparanase controls tumor invasion and immune surveillance.

NK cell heparanase controls tumor invasion and immune surveillance.

Journal: The Journal of clinical investigation

Published: July 01, 2024

Correction: DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells.

Correction: DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 27, 2024

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Journal: Nature immunology

Published: March 22, 2024

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Journal: Nature immunology

Published: February 15, 2024

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Journal: The Journal of clinical investigation

Published: December 15, 2023

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Journal: Nature immunology

Published: December 12, 2023

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

Journal: The Journal of clinical investigation

Published: March 15, 2022

Showing 1-12 of 283

Last Updated: 09/26/2026